Q² Solutions Receives 2016 Global Supplier Award from Eli Lilly and Company
By Default Author
By Default Author
Driving operational improvements and quality of our services
Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas
We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.
DownloadOur commitment to customer success is embedded in every facet of our operations.
Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas
Driving operational improvements and quality of our services
Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
Search jobsWe are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.
DownloadOur labs bring expertise in protein production, antibody discovery, and immunogenicity to help you select the most promising candidates and reduce risk as you move toward IND-enabling studies.
a CLIA-certified biomarker testing laboratory developing immunoassays used to quantify protein biomarkers in support of drug mechanism of action, pharmacodynamic, prognostic, and predictive clinical studies across all stages of drug discovery and development.
Meeting the demands of today’s drug, device and diagnostics development environment requires a next generation service provider.
One of the world's largest and most respected bioanalytical and ADME laboratory networks. From our global locations, we serve many of the largest pharmaceutical, specialty pharmaceutical and biotechnology companies worldwide.
We offer a range of genomic laboratory services to support drug discovery, precision medicine and clinical development. Our industry-leading team advances research by delivering scientific insights that help clients maximize the value of their data.
Combining cutting-edge technology platforms and state-of-the-art laboratories with over 35 years of clinical vaccine development.
We have a dedicated Digital Innovation department focused on driving operational improvements and quality of our services. We’ve helped create agile and impactful solutions across the organization with the underpinnings of traceability, productivity, quality, and efficiency.
By Default Author
MORRISVILLE, N.C. – June 23, 2016 – Q2 Solutions, a global clinical trials laboratory services organization, today announced that the company has received the 2016 Lilly Global Supplier Award. Q2 Solutions was one of twelve companies to receive the award this year, recognizing the company’s ongoing contributions to Lilly’s drug development efforts.
Each year, the Lilly Global Supplier Award recognizes suppliers who have worked collaboratively to deliver a positive and measurable impact on Lilly’s corporate objectives and priorities. Lilly presented the award to Q2 Solutions representatives during a special ceremony in Indianapolis, Ind.
“It is a tremendous honor to receive this prestigious recognition from Lilly,” said Costa Panagos, chief executive officer, Q2 Solutions. “To earn this award in our first year as an organization is a testament to our employees’ dedication to scientific excellence and on-time, quality delivery. We are proud to be recognized for our work with Lilly; work that we know will help improve human health through innovation that transforms science and data into actionable medical insights.”
About Q2 Solutions
Launched in 2015, Q2 Solutions is a global clinical trials laboratory services organization that helps biopharmaceutical, medical device and diagnostics customers improve human health through innovation that transforms science and data into actionable medical insights. Q2 Solutions is a joint venture formed by Quintiles and Quest Diagnostics, combining the clinical trials laboratory services of each parent organization. To learn more, visit www.q2labsolutions.com.
Contacts:
Phil Bridges, Media Relations (phil.bridges@quintiles.com)
+1.919.457.6347
Todd Kasper, Investor Relations (InvestorRelations@quintiles.com)
+1.919.998.2590
By Default Author